Steven Leonard Chapman - Jul 2, 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Jul 2, 2021
Transactions value $
-$3,470,770
Form type
4
Date filed
7/7/2021, 08:07 PM
Previous filing
Jun 29, 2021
Next filing
Aug 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise +3.13K +4.19% 77.8K Jul 2, 2021 Direct F1, F2
transaction NTRA Common Stock Options Exercise +9.38K +12.06% 87.1K Jul 2, 2021 Direct F2, F3
transaction NTRA Common Stock Sale -$185K -1.56K -1.79% $118.59 85.6K Jul 6, 2021 Direct F4
transaction NTRA Common Stock Options Exercise $22.3K +2.4K +2.81% $9.29* 88K Jul 6, 2021 Direct
transaction NTRA Common Stock Options Exercise $30.8K +2.37K +2.69% $13.01* 90.3K Jul 6, 2021 Direct
transaction NTRA Common Stock Options Exercise $107K +8.2K +9.08% $13.01* 98.5K Jul 6, 2021 Direct
transaction NTRA Common Stock Options Exercise $48K +2.37K +2.4% $20.27 101K Jul 6, 2021 Direct
transaction NTRA Common Stock Options Exercise $125K +4.92K +4.88% $25.46 106K Jul 6, 2021 Direct
transaction NTRA Common Stock Options Exercise $290 +27 +0.03% $10.73* 106K Jul 6, 2021 Direct
transaction NTRA Common Stock Sale -$704K -6.05K -5.71% $116.43 99.8K Jul 6, 2021 Direct F5, F6
transaction NTRA Common Stock Sale -$1.59M -13.5K -13.57% $117.13 86.3K Jul 6, 2021 Direct F5, F7
transaction NTRA Common Stock Sale -$83.8K -708 -0.82% $118.37 85.6K Jul 6, 2021 Direct F5, F8
transaction NTRA Common Stock Sale -$331K -2.84K -3.31% $116.59 82.7K Jul 6, 2021 Direct F5, F9
transaction NTRA Common Stock Sale -$366K -3.13K -3.78% $117.24 79.6K Jul 6, 2021 Direct F5, F10
transaction NTRA Common Stock Sale -$2.02K -17 -0.02% $118.59 79.6K Jul 6, 2021 Direct F5
transaction NTRA Common Stock Sale -$547K -4.63K -5.82% $117.98 75K Jul 7, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Restricted Stock Unit Options Exercise $0 -3.13K -14.29% $0.00 18.8K Jul 2, 2021 Common Stock 3.13K Direct F2, F11
transaction NTRA Restricted Stock Unit Options Exercise $0 -9.38K -50% $0.00 9.38K Jul 2, 2021 Common Stock 9.38K Direct F2, F12
transaction NTRA Stock Option (right to buy) Options Exercise $0 -2.4K -7% $0.00 31.9K Jul 6, 2021 Common Stock 2.4K $9.29 Direct F13
transaction NTRA Stock Option (right to buy) Options Exercise $0 -2.37K -5.35% $0.00 41.9K Jul 6, 2021 Common Stock 2.37K $13.01 Direct F14
transaction NTRA Stock Option (right to buy) Options Exercise $0 -8.2K -15% $0.00 46.5K Jul 6, 2021 Common Stock 8.2K $13.01 Direct F15
transaction NTRA Stock Option (right to buy) Options Exercise $0 -2.37K -4.69% $0.00 48.2K Jul 6, 2021 Common Stock 2.37K $20.27 Direct F16
transaction NTRA Stock Option (right to buy) Options Exercise $0 -4.92K -15% $0.00 27.9K Jul 6, 2021 Common Stock 4.92K $25.46 Direct F17
transaction NTRA Stock Option (right to buy) Options Exercise $0 -27 -35.06% $0.00 50 Jul 6, 2021 Common Stock 27 $10.73 Direct F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") starting January 2, 2020.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 Represents the partial vesting and settlement of RSUs starting October 1, 2020.
F4 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
F5 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.75 to $116.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.76 to $117.6150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.82 to $118.59 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.91 to $116.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.97 to $117.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
F12 On March 27, 2020, the Reporting Person was granted a RSU, which vests in three tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Issuer's stock price. On July 2, 2021, the Issuer's Board of Directors determined that the milestone for the second tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.
F13 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
F14 The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F15 This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to 31,250 additional shares.
F16 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F17 The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.
F18 The option shares are fully vested and may be exercised at any time.